Results 161 to 170 of about 2,492,664 (191)

The use of rituximab, anti‐CD20 monoclonal antibody, in pediatric transplantation

Pediatric Transplantation, 2004
Abstract:  Rituximab, chimeric anti‐human CD20, is approved for treatment of B‐cell lymphoma in adults. It is being used experimentally in other various immune related disease such as immune thrombocytopenic purpura, myasthenia gravis, and rheumatoid arthritis.
openaire   +2 more sources

Anti-CD20 monoclonal antibody

2006
NUMAZAKI MASANORI, NAKAMURA TETSUO, USUDA SADAKAZU, PADLAN EDUARDO A   +3 more
openaire   +6 more sources

New and Old Anti-CD20 Monoclonal Antibodies for Nephrotic Syndrome. Where We Are?

Frontiers in Immunology, 2022
Andrea Angeletti, Gian Marco Ghiggeri, Biswanath Basu   +2 more
exaly  

Anti-CD20-monoclonal-antibody/immune-globulin

Reactions Weekly, 2022
openaire   +1 more source

The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment

Neurology and Therapy, 2023
Stephen L. Hauser, David Paling, Goeril Karlsson   +2 more
exaly  

Successful Use of Casirivimab/Imdevimab Anti-Spike Monoclonal Antibodies to Enhance Neutralizing Antibodies in a Woman on Anti-CD20 Treatment With Refractory COVID-19

Journal of Infection and Chemotherapy, 2022
Kei Yamamoto, Yuki Takamatsu, Hiroaki Mitsuya   +2 more
exaly  

New Developments in Monoclonal Antibodies for Cancer Detection Andtherapy

Ca-A Cancer Journal for Clinicians, 1994
David M Goldenberg
exaly  

Flashback Foreword: Chimeric Anti-CD20 Monoclonal Antibody Therapy

Journal of Clinical Oncology, 2023
openaire   +2 more sources

Anti-CD20 Monoclonal Antibodies in Multiple Sclerosis

Expert Review of Neurotherapeutics, 2017
Irene Moreno Torres, Antonio García-Merino   +1 more
exaly  

Anti-CD20 monoclonal antibody/thalidomide

Reactions Weekly, 2001
openaire   +1 more source